You are here

Novartis

Novartis gets FDA okay for frontline use of Scemblix in CML

Pharmaphorum

Wed, 10/30/24 - 11:38 am

Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years

Fierce Biotech

Tue, 10/29/24 - 11:44 am

Monte Rosa joins with Novartis in ‘molecular glue’ drug deal

BioPharma Dive

Mon, 10/28/24 - 11:36 am

molecular glue degrader

Novartis eyes year-end filing in US for Fabhalta in C3G

Pharmaphorum

Mon, 10/28/24 - 10:17 am

C3 glomerulopathy

Novartis falls short in legal effort to undo FDA approval of MSN's Entresto generic

Fierce Pharma

Thu, 10/17/24 - 08:50 pm

MSN Pharmaceuticals

Novartis loses latest bid to block generic version of blockbuster heart drug

Reuters

Thu, 10/17/24 - 09:26 am

1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move

Motley Fool

Thu, 10/17/24 - 09:24 am

Novartis terminating midphase SMURF1 trial

Fierce Biotech

Mon, 10/14/24 - 10:19 am

clinical trials

Novartis inks $1B-plus biobucks deal with Flagship's Generate

Fierce Biotech

Tue, 09/24/24 - 11:41 am

Generate Biomedicines

protein therapeutics

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

CNBC

Thu, 09/19/24 - 11:13 am

Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer

Fierce Pharma

Tue, 09/17/24 - 11:08 pm

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction

Clinical Trials Arena

Mon, 09/16/24 - 10:56 am

clinical trials

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival

Fierce Pharma

Fri, 09/13/24 - 11:12 am

renal cell carcinoma

clinical trials

Novartis ignites new stage of Voyager pact with $15M capsid deal

Fierce Biotech

Thu, 09/5/24 - 11:28 am

Voyager Therapeutics

Novartis builds out radiopharma production with expansion, new factory

BioPharma Dive

Wed, 09/4/24 - 10:44 pm

radiopharmaceuticals

Pharma’s ‘it’ therapy — a new drug class gaining steam

Pharma Voice

Wed, 09/4/24 - 11:30 am

protein degradation

Novartis and Genentech’s Xolair is rising rapidly on TV

Medical Marketing and Media

Thu, 08/29/24 - 06:11 pm

Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line

Fierce Pharma

Wed, 08/28/24 - 11:46 am

Lindy Biosciences

Novartis builds case for Leqvio with monotherapy data

Pharmaphorum

Wed, 08/28/24 - 11:29 am

clinical trials

Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats

Investors Business Daily

Mon, 08/26/24 - 11:11 am

non-Hodgkin lymphoma

Gilead Sciences

Pages